Skip to main content
Log in

Stiffer-Matrix-Induced PGC-1α Upregulation Enhanced Mitochondrial Biogenesis and Oxidative Stress Resistance in Non-small Cell Lung Cancer

  • Original Article
  • Published:
Cellular and Molecular Bioengineering Aims and scope Submit manuscript

Abstract

Introduction

Metabolic strategies in different microenvironments can affect cancer metabolic adaptation, ultimately influencing the therapeutic response. Understanding the metabolic alterations of cancer cells in different microenvironments is critical for therapeutic success.

Methods

In this study, we cultured non-small cell lung cancer cells in three different microenvironments (two-dimensional (2D) plates, soft elastic three-dimensional (3D) porous 2 wt% scaffolds, and stiff elastic 3D porous 4 wt% scaffolds) to investigate the effects of different matrix elasticity as well as 2D and 3D culture settings on the metabolic adaptation of cancer cells.

Results

The results revealed that PGC-1α expression is sensitive to the elasticity of the 3D scaffold. PGC-1α expression was markedly increased in cancer cells cultured in stiff elastic 3D porous 4 wt% scaffolds compared with cells cultured in soft elastic 3D porous 2 wt% scaffolds or 2D plates, enhancing mitochondrial biogenesis and oxidative stress resistance of non-small cell lung cancer through increased reactive oxygen species (ROS) detoxification capacity. However, phosphofructokinase-1 (PFK-1) expression, a key rate-limiting enzyme in glycolysis, did not change significantly in the three microenvironments, indicating that microenvironments may not affect the early stage of glycolysis. Conversely, monocarboxylate transporter 1 (MCT1) expression in 3D culture was significantly reduced compared to 2D culture but without significant difference between soft and stiff scaffolds, indicating that MCT1 expression is more sensitive to the shape of the different cultures of 2D and 3D microenvironment surrounding cells but is unaffected by the scaffold elasticity.

Conclusions

Together, these results demonstrate that differences in the microenvironment of cancer cells profoundly impact their metabolic response.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

Abbreviations

ECM:

Extracellular matrix

GAGs:

Glycosaminoglycans

MCT1:

Monocarboxylate transporter

PEC:

Polyacrylic complex

PFK-1:

Phosphofructokinase-1

ROS:

Reactive oxygen species

PGC-1α:

Transcription coactivator peroxisome proliferator-activated receptor gamma

SOD2:

Manganese superoxide dismutase

SOD1:

Recombinant superoxide dismutase 1

TBST:

Tris-buffered saline with TweenR 20

TCA:

Tricarboxylic acid

3D:

Three-dimensional

2D:

Two-dimensional

References

  1. Barbosa, I. A., N. G. Machado, A. J. Skildum, P. M. Scott, and P. J. Oliveira. Mitochondrial remodeling in cancer metabolism and survival: potential for new therapies. Biochim. Biophys. Acta (BBA). 238–254:2012, 1826.

    Google Scholar 

  2. Beloueche-Babari, M., et al. MCT1 inhibitor AZD3965 increases mitochondrial metabolism, facilitating combination therapy and noninvasive magnetic resonance spectroscopy. Cancer Res. 77:5913–5924, 2017.

    Article  Google Scholar 

  3. Bissell, M. J., and W. C. Hines. Why don’t we get more cancer? A proposed role of the microenvironment in restraining cancer progression. Nat. Med. 17:320–329, 2011.

    Article  Google Scholar 

  4. Cazzaniga, M., and B. Bonanni. Relationship between metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical implications. Anticancer Res. 35:5789–5796, 2015.

    Google Scholar 

  5. Cheng, G., et al. Mitochondria-targeted drugs synergize with 2-deoxyglucose to trigger breast cancer cell death. Cancer Res. 72:2634–2644, 2012.

    Article  Google Scholar 

  6. Cheng, G., J. Zielonka, D. McAllister, S. Tsai, M. B. Dwinell, and B. Kalyanaraman. Profiling and targeting of cellular bioenergetics: inhibition of pancreatic cancer cell proliferation. Br. J. Cancer. 111:85–93, 2014.

    Article  Google Scholar 

  7. Cox, T. R., and J. T. Erler. Remodeling and homeostasis of the extracellular matrix: implications for fibrotic diseases and cancer. Dis. Model. Mech. 4:165–178, 2011.

    Article  Google Scholar 

  8. Doench, J. G. Am I ready for CRISPR? A user’s guide to genetic screens. Nat. Rev. Genet. 19:67–80, 2018.

    Article  Google Scholar 

  9. Fantin, V. R., J. St-Pierre, and P. Leder. Attenuation of LDH-a expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance. Cancer Cell. 9:425–434, 2006.

    Article  Google Scholar 

  10. Faubert, B., et al. Lactate metabolism in human lung tumors. Cell. 171:358–371, 2017.

    Article  Google Scholar 

  11. Florczyk, S. J., F. M. Kievit, K. Wang, A. E. Erickson, R. G. Ellenbogen, and M. Zhang. 3D porous chitosan–alginate scaffolds promote proliferation and enrichment of cancer stem-like cells. J. Mater. Chem. B. 4:6326–6334, 2016.

    Article  Google Scholar 

  12. Gao, Y., K. Peng, and S. Mitragotri. Covalently crosslinked hydrogels via step-growth reactions: crosslinking chemistries, polymers, and clinical impact. Adv. Mater. 33:2006362, 2021.

    Article  Google Scholar 

  13. Gargiulo, G., M. Serresi, M. Cesaroni, D. Hulsman, and M. Van Lohuizen. In vivo shRNA screens in solid tumors. Nat. Protoc. 9:2880–2902, 2014.

    Article  Google Scholar 

  14. Gottlieb, E., and I. P. M. Tomlinson. Mitochondrial tumour suppressors: a genetic and biochemical update. Nat. Rev. Cancer. 5:857–866, 2005.

    Article  Google Scholar 

  15. Halestrap, A. P. Monocarboxylic acid transport. Compr. Physiol. 3:1611–1643, 2013.

    Article  Google Scholar 

  16. Handschin, C., et al. Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in PGC-1α muscle-specific knock-out animals. J. Biol. Chem. 282:30014–30021, 2007.

    Article  Google Scholar 

  17. Hutmacher, D. W. Biomaterials offer cancer research the third dimension. Nat. Mater. 9:90–93, 2010.

    Article  Google Scholar 

  18. Jose, C., N. Bellance, and R. Rossignol. Choosing between glycolysis and oxidative phosphorylation: a tumor’s dilemma? Biochim. Biophys. Acta (BBA). 552–561:2011, 1807.

    Google Scholar 

  19. Kirdponpattara, S., A. Khamkeaw, N. Sanchavanakit, P. Pavasant, and M. Phisalaphong. Structural modification and characterization of bacterial cellulose–alginate composite scaffolds for tissue engineering. Carbohydr. Polym. 132:146–155, 2015.

    Article  Google Scholar 

  20. Koppenol, W. H., P. L. Bounds, and C. V. Dang. Otto Warburg’s contributions to current concepts of cancer metabolism. Nat. Rev. Cancer. 11:325–337, 2011.

    Article  Google Scholar 

  21. LeBleu, V. S., et al. PGC-1α mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16:992–1003, 2014.

    Article  Google Scholar 

  22. Li, Z., H. R. Ramay, K. D. Hauch, D. Xiao, and M. Zhang. Chitosan–alginate hybrid scaffolds for bone tissue engineering. Biomaterials. 26:3919–3928, 2005.

    Article  Google Scholar 

  23. Luengo, A., D. Y. Gui, and M. G. Vander Heiden. Targeting metabolism for cancer therapy. Cell Chem. Biol. 24:1161–1180, 2017.

    Article  Google Scholar 

  24. Marchiq, I., R. Le Floch, D. Roux, M.-P. Simon, and J. Pouyssegur. Genetic disruption of lactate/H+ symporters (MCTs) and their subunit CD147/BASIGIN sensitizes glycolytic tumor cells to phenformin. Cancer Res. 75:171–180, 2015.

    Article  Google Scholar 

  25. Matoba, S., et al. p53 regulates mitochondrial respiration. Science (80-). 312:1650–1653, 2006.

    Article  Google Scholar 

  26. McMillan, E. A., et al. Chemistry-first approach for nomination of personalized treatment in lung cancer. Cell. 173:864–878, 2018.

    Article  Google Scholar 

  27. Michelakis, E. D., et al. Metabolic modulation of glioblastoma with dichloroacetate. Sci. Transl. Med. 2:31ra34-31ra34, 2010.

    Article  Google Scholar 

  28. Moreno-Sánchez, R., S. Rodriguez-Enriquez, A. Marin-Hernández, and E. Saavedra. Energy metabolism in tumor cells. FEBS J. 274:1393–1418, 2007.

    Article  Google Scholar 

  29. Ozel, D., R. Y. Bayraktarli, and Z. U. Coskun. Re: Shear wave elastography for localization of prostate cancer lesions and assessment of elasticity thresholds: implications for targeted biopsies and active surveillance protocols. J. Urol. 193:794–800, 2015.

    Article  Google Scholar 

  30. Park, J. S., et al. Mechanical regulation of glycolysis via cytoskeleton architecture. Nature. 578:621–626, 2020.

    Article  Google Scholar 

  31. Samani, A., J. Zubovits, and D. Plewes. Elastic moduli of normal and pathological human breast tissues: an inversion-technique-based investigation of 169 samples. Phys. Med. Biol. 52:1565, 2007.

    Article  Google Scholar 

  32. Sancho, P., D. Barneda, and C. Heeschen. Hallmarks of cancer stem cell metabolism. Br. J. Cancer. 114:1305–1312, 2016.

    Article  Google Scholar 

  33. St-Pierre, J., et al. Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell. 127:397–408, 2006.

    Article  Google Scholar 

  34. Sullivan, L. B., and N. S. Chandel. Mitochondrial reactive oxygen species and cancer. Cancer Metab. 2:1–12, 2014.

    Article  Google Scholar 

  35. Tasdogan, A., et al. Metabolic heterogeneity confers differences in melanoma metastatic potential. Nature. 577:115–120, 2020.

    Article  Google Scholar 

  36. Vazquez, F., et al. PGC1$α$ expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. Cancer Cell. 23:287–301, 2013.

    Article  Google Scholar 

  37. Viswanathan, V. S., et al. Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway. Nature. 547:453–457, 2017.

    Article  Google Scholar 

  38. Wang, K., F. M. Kievit, S. J. Florczyk, Z. R. Stephen, and M. Zhang. 3D porous chitosan–alginate scaffolds as an in vitro model for evaluating nanoparticle-mediated tumor targeting and gene delivery to prostate cancer. Biomacromolecules. 16:3362–3372, 2015.

    Article  Google Scholar 

  39. Warburg, O. On the origin of cancer cells. Science. 123:309–314, 1956.

    Article  Google Scholar 

  40. Wellman, P., R.D. Howe, E. Dalton, and K.A. Kern. Breast tissue stiffness in compression is correlated to histological diagnosis. Harvard BioRobotics Lab. Tech. Rep. 1, 1999.

  41. Xu, K., et al. 3D porous chitosan-alginate scaffold stiffness promotes differential responses in prostate cancer cell lines. Biomaterials.217:119311, 2019.

    Article  Google Scholar 

  42. Yu, H., J. K. Mouw, and V. M. Weaver. Forcing form and function: biomechanical regulation of tumor evolution. Trends Cell Biol. 21:47–56, 2011.

    Article  Google Scholar 

Download references

Acknowledgments

This work was supported by the Japan Society for the Promotion of Science under Grants-in-Aid for Scientific Research (S; No. 17H06146). Xiaorong Fu acknowledges the support of the China Scholarship Council (Grant Number 201906050131).

Author Contributions

XF: Investigation, Methodology, Visualization, Writing-original draft, Writing- review & editing. YK: Resources, Investigation, Methodology, Writing-review & editing. YT: Resources, Writing-review & editing. GS: Resources, Writing- review & editing. YJ: Conceptualization, Supervision, Writing- original draft, Writing- review & editing, Funding acquisition.

Data Availability

The datasets used and/or analyzed during the current study are available from the corresponding author upon reasonable request.

Conflict of interest

X.F., Y.K., Y.T., G.S., and Y.J. declare that they have no financial, professional, or personal conflict of interest.

Ethical Approval

No animal or human studies were carried out by the authors of this article.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yang Ju.

Additional information

Associate Editor Michael R. King oversaw the review of this article.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, X., Kimura, Y., Toku, Y. et al. Stiffer-Matrix-Induced PGC-1α Upregulation Enhanced Mitochondrial Biogenesis and Oxidative Stress Resistance in Non-small Cell Lung Cancer. Cel. Mol. Bioeng. 16, 69–80 (2023). https://doi.org/10.1007/s12195-022-00751-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12195-022-00751-x

Keywords

Navigation